SL Science Holding Limited (SLBT)
NASDAQ: SLBT · Real-Time Price · USD
4.730
+0.170 (3.73%)
At close: Jul 10, 2026, 4:00 PM EDT
4.670
-0.060 (-1.27%)
Pre-market: Jul 13, 2026, 5:12 AM EDT
Company Description
SL Science Holding Limited manufactures cosmetic skin care and scalp care products.
The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series.
It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes.
SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026.
The company is based in Taipei, Taiwan.
Contact Details
Address: No. 479, Chongyang Rd., 11th Floor, Nangang Dist. Taipei, 115010 Taiwan | |
| Phone | 886 2 2651 6826 |
| Website | sl-bio.com |
Stock Details
| Ticker Symbol | SLBT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Reporting Currency | USD |
| CIK Code | 2070534 |
| CUSIP Number | G8191L116 |
| ISIN Number | KYG8191L1169 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Ching-Dong Wang | Founder, Chairman and Chief Executive Officer |
| Ray Leung | Chief Financial Officer and Director |
| Dr. Ethan Shen Ph.D. | Chief Technology Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2026 | 6-K | Report of foreign issuer |
| Jun 18, 2026 | SCHEDULE 13D | Filing |
| Jun 18, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Jun 15, 2026 | 6-K | Report of foreign issuer |
| Jun 12, 2026 | CERT | Certification by an exchange approving securities for listing |
| Jun 11, 2026 | 8-A12B | Registration of securities |
| Jan 13, 2026 | EFFECT | Notice of Effectiveness |
| Jan 13, 2026 | 424B3 | Prospectus |
| Jan 7, 2026 | F-4/A | Filing |
| Dec 18, 2025 | F-4 | Filing |